» Articles » PMID: 25412185

Pathophysiologic and Transcriptomic Analyses of Viscerotropic Yellow Fever in a Rhesus Macaque Model

Overview
Date 2014 Nov 21
PMID 25412185
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with yellow fever virus (YFV), an explosively replicating flavivirus, results in viral hemorrhagic disease characterized by cardiovascular shock and multi-organ failure. Unvaccinated populations experience 20 to 50% fatality. Few studies have examined the pathophysiological changes that occur in humans during YFV infection due to the sporadic nature and remote locations of outbreaks. Rhesus macaques are highly susceptible to YFV infection, providing a robust animal model to investigate host-pathogen interactions. In this study, we characterized disease progression as well as alterations in immune system homeostasis, cytokine production and gene expression in rhesus macaques infected with the virulent YFV strain DakH1279 (YFV-DakH1279). Following infection, YFV-DakH1279 replicated to high titers resulting in viscerotropic disease with ∼72% mortality. Data presented in this manuscript demonstrate for the first time that lethal YFV infection results in profound lymphopenia that precedes the hallmark changes in liver enzymes and that although tissue damage was noted in liver, kidneys, and lymphoid tissues, viral antigen was only detected in the liver. These observations suggest that additional tissue damage could be due to indirect effects of viral replication. Indeed, circulating levels of several cytokines peaked shortly before euthanasia. Our study also includes the first description of YFV-DakH1279-induced changes in gene expression within peripheral blood mononuclear cells 3 days post-infection prior to any clinical signs. These data show that infection with wild type YFV-DakH1279 or live-attenuated vaccine strain YFV-17D, resulted in 765 and 46 differentially expressed genes (DEGs), respectively. DEGs detected after YFV-17D infection were mostly associated with innate immunity, whereas YFV-DakH1279 infection resulted in dysregulation of genes associated with the development of immune response, ion metabolism, and apoptosis. Therefore, WT-YFV infection is associated with significant changes in gene expression that are detectable before the onset of clinical symptoms and may influence disease progression and outcome of infection.

Citing Articles

Wild Brazilian yellow fever virus infection in Syrian hamsters (Mesocricetus auratus): Clinical and histopathological analyses.

de Oliveira Bottino F, Euzebio Pereira Dias de Oliveira B, Rodrigues Dos Santos J, Barata Viana Tiradentes M, Rodrigues Maia de Souza Y, Silva Galdino de Paula T Virus Res. 2024; 350:199505.

PMID: 39622385 PMC: 11667703. DOI: 10.1016/j.virusres.2024.199505.


Potential role of heterologous flavivirus immunity in preventing urban transmission of yellow fever virus.

Shinde D, Plante J, Scharton D, Mitchell B, Walker J, Azar S Nat Commun. 2024; 15(1):9728.

PMID: 39523371 PMC: 11551182. DOI: 10.1038/s41467-024-54146-9.


Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model.

Amanna I, Thomas A, Engelmann F, Hammarlund E, Raue H, Bailey A Cell Rep Med. 2024; 5(7):101655.

PMID: 39019010 PMC: 11293362. DOI: 10.1016/j.xcrm.2024.101655.


Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination.

Mantel N, Piras-Douce F, Chautard E, Marcos-Lopez E, Bodinham C, Cosma A J Virol. 2024; 98(5):e0151623.

PMID: 38567951 PMC: 11092345. DOI: 10.1128/jvi.01516-23.


Comparative Analysis of Human Hepatic Lesions in Dengue, Yellow Fever, and Chikungunya: Revisiting Histopathological Changes in the Light of Modern Knowledge of Cell Pathology.

Ribeiro Y, Falcao L, Smith V, de Sousa J, Pagliari C, Franco E Pathogens. 2023; 12(5).

PMID: 37242350 PMC: 10222210. DOI: 10.3390/pathogens12050680.


References
1.
Eckfeld K, Hesson L, Vos M, Bieche I, Latif F, Clark G . RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res. 2004; 64(23):8688-93. DOI: 10.1158/0008-5472.CAN-04-2065. View

2.
Tomori O . Yellow fever: the recurring plague. Crit Rev Clin Lab Sci. 2004; 41(4):391-427. DOI: 10.1080/10408360490497474. View

3.
Quaresma J, Barros V, Fernandes E, Pagliari C, Guedes F, da Costa Vasconcelos P . Immunohistochemical examination of the role of Fas ligand and lymphocytes in the pathogenesis of human liver yellow fever. Virus Res. 2005; 116(1-2):91-7. DOI: 10.1016/j.virusres.2005.08.019. View

4.
Stempniak M, Hostomska Z, Nodes B, Hostomsky Z . The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme. J Virol. 1997; 71(4):2881-6. PMC: 191414. DOI: 10.1128/JVI.71.4.2881-2886.1997. View

5.
Pulendran B, Miller J, Querec T, Akondy R, Moseley N, Laur O . Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis. 2008; 198(4):500-7. PMC: 3734802. DOI: 10.1086/590187. View